MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.490
+0.020 (0.58%)
Apr 14, 2026, 4:00 PM EDT - Market closed
MacroGenics Employees
MacroGenics had 293 employees as of December 31, 2025. The number of employees decreased by 48 or -14.08% compared to the previous year.
Employees
293
Change (1Y)
-48
Growth (1Y)
-14.08%
Revenue / Employee
$510,239
Profits / Employee
-$254,676
Market Cap
221.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | -48 | -14.08% |
| Dec 31, 2024 | 341 | 2 | 0.59% |
| Dec 31, 2023 | 339 | -18 | -5.04% |
| Dec 31, 2022 | 357 | -70 | -16.39% |
| Dec 31, 2021 | 427 | 57 | 15.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Codexis | 146 |
| MediWound | 121 |
| OmniAb | 89 |
| Keros Therapeutics | 78 |
| Camp4 Therapeutics | 48 |
| ALX Oncology Holdings | 43 |
| Fennec Pharmaceuticals | 35 |
MGNX News
- 6 days ago - FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study - GlobeNewsWire
- 5 weeks ago - MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures - GlobeNewsWire
- 6 weeks ago - MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial - GlobeNewsWire
- 5 months ago - MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 5 months ago - MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress - GlobeNewsWire
- 5 months ago - MacroGenics to Participate in the Stifel 2025 Healthcare Conference - GlobeNewsWire
- 8 months ago - MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire